Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer

Volume:19   Issue: 8
Pp: 595-630
Tatsuya Nagano*, Motoko Tachihara and Yoshihiro Nishimura
DOI: 10.2174/1568009619666181210114559
Published on: 06 September, 2019

Bone Invasive Properties of Oral Squamous Cell Carcinoma and its Interactions with Alveolar Bone Cells: An In Vitro Study

Volume:19   Issue: 8
Pp: 631-640
Omel Baneen Qallandar, Faeza Ebrahimi, Farhadul Islam, Riajul Wahab, Bin Qiao, Peter Reher, Vinod Gopalan* and Alfred King-yin Lam*
DOI: 10.2174/1568009618666181102144317
Published on: 06 September, 2019

Gender Differences in the Antioxidant Response to Oxidative Stress in Experimental Brain Tumors

Volume:19   Issue: 8
Pp: 641-654
María Jesús Ramírez-Expósito, María Dolores Mayas, María Pilar Carrera-González and José Manuel Martínez-Martos*
DOI: 10.2174/1568009618666181018162549
Published on: 06 September, 2019

CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK

Volume:19   Issue: 8
Pp: 655-665
Caixia Liang, Ningning Zhang, Qiaoyun Tan, Shuxia Liu, Rongrong Luo, Yanrong Wang, Yuankai Shi* and Xiaohong Han*
DOI: 10.2174/1568009618666181031152140
Published on: 06 September, 2019

Osimertinib Quantitative and Gene Variation Analyses in Cerebrospinal Fluid and Plasma of a Non-small Cell Lung Cancer Patient with Leptomeningeal Metastases

Volume:19   Issue: 8
Pp: 666-673
Yuanyuan Song, Peng Liu, Yu Huang, Yanfang Guan, Xiaohong Han* and Yuankai Shi*
DOI: 10.2174/1568009618666181017114111
Published on: 06 September, 2019

Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis

Volume:19   Issue: 8
Pp: 674-680
Lei Lei, Yuan Wang, Yi-Wen Zheng, Liang-Ru Fei, Hao-Yue Shen, Zhi-Han Li, Wen-Jing Huang, Juan-Han Yu and Hong-Tao Xu*
DOI: 10.2174/1568009618666181119150521
Published on: 06 September, 2019